Record Annual Revenue and Growth
Net revenue grew 25% year-over-year to a record $810 million for fiscal 2025, ahead of long-term target and company plan.
Strong Profitability Metrics
Delivered record adjusted EBITDA of $163 million with a 20.2% adjusted EBITDA margin (consistent with the 20% long-term target); adjusted diluted EPS of $2.21 for the full year 2025.
Q4 Outperformance
Fourth-quarter net revenue increased 24% year-over-year to $153 million, exceeding guidance (21%–23%); Q4 adjusted EBITDA of $13 million and adjusted diluted EPS of $0.20, both above guidance.
High Repeat Sales and Customer Retention
Approximately 70% of 2025 revenue came from repeat sales; 12-month net revenue repeat rates for the 2024 cohort exceeded 100% and improved versus the 2023 cohort—supporting long-term unit economics.
Brand and Product Momentum
IL MAKIAGE grew low double digits to ~ $560 million; IL MAKIAGE Skin rose to ~40% of brand revenue (from ~30% in 2024). SpoiledChild grew double digits to ~ $250 million. Launched third brand METHODIQ with early success and app engagement metrics showing positive KPI trends.
International Expansion
ODDITY International revenue grew 42% for the year and now represents 17.5% of total net revenue, driving incremental growth outside the U.S.
Investment in R&D and Product Pipeline
Continued build-out of ODDITY LABS (in silico, in vitro and traditional biology, new peptide capabilities). Company expects 8 products in market in 2026 using ODDITY LABS molecules, indicating meaningful product pipeline progress.
Strong Balance Sheet and Cash Generation
Ended year with $776 million in cash and equivalents, generated $84 million of free cash flow for 2025, amended credit facilities expanded borrowing capacity to $350 million (undrawn), and $103 million remaining on share repurchase authorization.